Kalamazoo Hematology & Oncology maintains affiliation with many pharmaceutical companies allowing us to provide clinical trials utilizing the newest therapies.

The list below contains all current pharmaceutical trials available to our patients.

KHO also participates in clinical trials approved by the National Cancer Institute through research bases such: Eastern Cooperative Oncology Group (ECOG), Univerisity of Rochester Cancer Center (URCC), University of Texas, M.D. Anderson Cancer Center (MDA), National Surgical Adjuvant Breast/Bowel Project (NSABP), University of Michigan Cancer Center (UMCC), Gynecologic Oncology Group (GOG) and Radiation Therapy Oncology Group (RTOG). KHO is also able to participate with Hoosier Oncology Group (HOG).

If you or someone you know would be interested in further information about any of the following studies, please feel free to contact the Clinical Trials Department by phone or email.